Newborn respiratory distress syndrome
Therapeutic area
Pulmonology
Rare disease
No
- Definition
- A condition beginning in the first day of life that results from inadequate surfactant production, causing increased work of breathing and impaired gas exchange.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Newborn respiratory distress syndrome
- Therapeutic area
- Pulmonology
- newborn respiratory distress syndrome
- RDS
- respiratory distress syndrome
- RDS Of newborns
- RDS, respiratory distress syndrome Of newborns
- hyaline membrane disease
- infant ARDS
- infant acute respiratory distress syndrome
- infant respiratory distress syndrome
- neonatal respiratory distress
- neonatal respiratory distress syndrome
- newborns (RDS), respiratory distress syndrome Of
- respiratory distress syndrome Of newborns
- respiratory distress syndrome Of newborns (RDS)
- respiratory distress syndrome in the newborn
- respiratory distress syndrome of newborn
- syndrome Of newborns (RDS), respiratory distress
- RDS of prematurity
- respiratory distress syndrome in premature infants
- NRDS
- RDS - infants
- respiratory distress syndrome, infant
- Disease mechanisms
- Syndromic
- All therapeutic areas
- Pulmonology
- Severity
- Severe
- MONDO ID
- MONDO:0700081
- Parent condition
- MONDO:0017015
Related records
Broader conditions (15)
- Acute disease
- Acute respiratory distress syndrome
- Acute respiratory failure
- Disease
- Disease by body system or component
- Human disease
- Interstitial lung disease
- Interstitial lung disease specific to childhood
- Lower respiratory tract disorder
- Lung disorder
- Pediatric acute respiratory distress syndrome
- Primary interstitial lung disease specific to childhood
- Respiratory failure
- Respiratory system disorder
- Syndromic disease
Narrower conditions (1)
- Respiratory distress syndrome in premature infants
Trials (1,526)
- "Continuous Positive Airway Pressure on Venovenous extracorporeaL Membrane Oxygenation for Acute respIratory Distress syndrOme"
- "Effectiveness of Delivery Room Bubble CPAP in Preterm Infants With Respiratory Distress
- (S5-SAMU) Randomized Study Comparing the ASV (Adaptative Support Ventilation) to Conventional Ventilation
- 5-HT3 Receptor Antagonist and Respiratory Drive in Patients With ARDS
- A Clinical Pharmacological Study of Dose Halving of Dexamethasone in Pregnant Women With Preterm Labour With Preterm Birth at Greater Than or Equal to 34 Gestational Weeks (34GW+)
- A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS
- A Clinical Study on Levosimendan Improvement of Prognosis of ARDS Patients by Optimizing Pulmonary Hemodynamics
- A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome
- A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS
- A Comparative Study Between Postextubation of Preterm Infants Into High-Flow Nasal Cannulae V.S Nasal Continuous Positive Airway Pressure
- A Comparative Study of Glucocorticoids Efficacy in Acute Respiratory Distress Syndrome
- A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation
- A Comparison of Optimal PEEP Determination Guided by EIT and Conventional Protective Ventilation Tool in ARDS Patients
- A Comparison of Optimal PEEP Determination Guided by EIT and G5 Device in Moderate and Severe ARDS Patients
- A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress
- A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact
- A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)
- A Low-Resource Oxygen Blender Prototype for Use in Modified Bubble CPAP Circuits
- A Modified Mathematical Model to Calculate Power Received by Mechanically Ventilated Patients With Different Etiologies
- A Multi-center Trial to Determine if Curosurf® Reduces the Duration of Mechanical Ventilation in Very Preterm Infants
Approved drugs (4)
- Beractant
- Calfactant
- Colfosceril palmitate
- Poractant alfa
Drugs in development (7)
- Beclomethasone dipropionate Phase 3
- Betamethasone Phase 2
- Budesonide Phase 3
- Lucinactant Phase 2
- Nitric oxide Phase 3
- Propofol Phase 3
- Sodium chloride Phase 2
Other linked drugs (4)
- Caffeine citrate
- Dexamethasone
- Dexmedetomidine
- Protirelin